Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept
Top Cited Papers
- 8 April 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 105 (9), e94-e95
- https://doi.org/10.1097/tp.0000000000003784
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 4 references indexed in Scilit:
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsJAMA, 2021
- Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical LaboratoriesJournal of Clinical Microbiology, 2021
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesThe New England Journal of Medicine, 2020
- Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritisArthritis Care & Research, 2013